Gates Foundation Trust’s CVS Health CVS Stock Holding History

Gates Foundation Trust’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-32,500	Closed	-$2.27M	–	36
2023 Q3	$2.27M	Buy	+32,500	New	+$2.3M	0.01%	58

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gates Foundation Trust's CVS Position: Q4 2023 in Review

Gates Foundation Trust sold out of CVS Health (CVS) in Q4 2023, closing a stake of 32,500 shares — an estimated $2.27M sold.

Gates Foundation Trust first reported a position in CVS in Q3 2023 and held it in 1 quarter. The position peaked at $2.27M in Q3 2023. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

Gates Foundation Trust reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
Gates Foundation Trust sold 32,500 CVS Health shares in Q4 2023, an estimated $2.27M.
Gates Foundation Trust first reported a position in CVS Health in Q3 2023 and held it in 1 quarter.
Gates Foundation Trust's CVS Health position peaked at $2.27M in Q3 2023.
2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Gates Foundation Trust's 13F filing for Q4 2023, filed 14 Feb 2024.